Novozymes OneHealth cultivates global probiotic market to help develop industry
chinadaily.com.cn Updated: May 29, 2023
The main businesses of OneHealth are currently gastrointestinal health, brain health, immune health, metabolism and oral health. In the development of probiotic products, OneHealth has bacterial strain products including Lactobacillus reuteri DSM17648, Bifidobacterium longum 35624 and Bifidobacterium longum 1714.
Most Read Stories
CONTACT US
Reach out to us for information on how we can facilitate your investment journey
* Please leave a message
* Your Email Address
SUBMIT
Copyright©2024 China Daily. All rights reserved.
